Small bowel obstruction due to metastatic colon cancer.
Systemic treatment, including monoclonal antibodies against tumor-associated targets, has increased the median survival of patients with metastatic colorectal cancer over 100% in the past few years. The prolonged life-span of these patients has led to the development of new and unusual complications that were typically not seen in the era of 5-fluorouracil and leucovorin. A multidisciplinary approach is now more crucial than ever. In this report, we will discuss a patient who presented with a metastatic lesion nearly obstructing the small bowel three years following the diagnosis of metastatic colon cancer.
Huerta
Sergio
S
aDepartments of Gastrointestinal and Endocrine Surgery, UT Southwestern Medical Center/VA North Texas Health Care System bMedicine Division of Hematology Oncology, Dallas, Texas, USA.
Li
Hsiao C
HC